Cargando…
Potential drawbacks of SARS-CoV-2 seroprevalence surveys
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834203/ https://www.ncbi.nlm.nih.gov/pubmed/33358929 http://dx.doi.org/10.1016/j.jhin.2020.12.011 |
| _version_ | 1783642229384937472 |
|---|---|
| author | Lippi, G. |
| author_facet | Lippi, G. |
| author_sort | Lippi, G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7834203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Healthcare Infection Society. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78342032021-01-26 Potential drawbacks of SARS-CoV-2 seroprevalence surveys Lippi, G. J Hosp Infect Letter to the Editor The Healthcare Infection Society. Published by Elsevier Ltd. 2021-04 2020-12-21 /pmc/articles/PMC7834203/ /pubmed/33358929 http://dx.doi.org/10.1016/j.jhin.2020.12.011 Text en © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Lippi, G. Potential drawbacks of SARS-CoV-2 seroprevalence surveys |
| title | Potential drawbacks of SARS-CoV-2 seroprevalence surveys |
| title_full | Potential drawbacks of SARS-CoV-2 seroprevalence surveys |
| title_fullStr | Potential drawbacks of SARS-CoV-2 seroprevalence surveys |
| title_full_unstemmed | Potential drawbacks of SARS-CoV-2 seroprevalence surveys |
| title_short | Potential drawbacks of SARS-CoV-2 seroprevalence surveys |
| title_sort | potential drawbacks of sars-cov-2 seroprevalence surveys |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834203/ https://www.ncbi.nlm.nih.gov/pubmed/33358929 http://dx.doi.org/10.1016/j.jhin.2020.12.011 |
| work_keys_str_mv | AT lippig potentialdrawbacksofsarscov2seroprevalencesurveys |